Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2025 | 04-2024 | 04-2023 | 04-2022 | 04-2021 | |
| Operating Expenses | 187,995 | 140,445 | 110,871 | 96,613 | 57,923 |
| Operating Income | -187,995 | -140,445 | -110,871 | -96,613 | -57,923 |
| Interest Expense | 5,785 | 0 | 0 | 0 | 0 |
| Other Income | 13,728 | 13,801 | 17,964 | 14,274 | 11,679 |
| Pre-tax Income | -180,052 | -126,644 | -92,907 | -82,339 | -46,244 |
| Income Tax | 3,392 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -183,444 | -126,644 | -92,907 | -82,339 | -46,244 |
| Net Income | $-183,444 | $-126,644 | $-92,907 | $-82,339 | $-46,244 |
| EPS Basic Total Ops | -3.69 | -3.44 | -3.33 | -3.36 | -2.42 |
| EPS Basic Continuous Ops | -3.69 | -3.44 | -3.33 | -3.36 | -2.42 |
| EPS Diluted Total Ops | -3.69 | -3.44 | -3.33 | -3.36 | -2.42 |
| EPS Diluted Continuous Ops | -3.69 | -3.44 | -3.33 | -3.36 | -2.42 |
| EBITDA(a) | $-187,040 | $-139,537 | $-109,165 | $-93,484 | $-56,701 |